§ Mr. BercowTo ask the Secretary of State for Health how many and what percentage of women in Buckingham with suspected breast cancer saw a specialist within two weeks in each of the last seven years. [161566]
§ Ms Rosie WintertonThe information requested is shown in the table. However, data are only available from 1999–2000.
597W
Waiting times for patients referred urgently by their GP with suspected breast cancer to first out-patient appointment: NHS Trusts in Buckinghamshire Quarter/NHS Trust Percentage of patients seen in two weeks Total Patients seen Patient seen in two weeks 1999–2000 Quarter 1 Milton Keynes General NHS Trust 94 49 46 South Buckinghamshire NHS Trust 96 82 79 stoke Mandeville Hospital NHS Trust 100 61 61 Quarter 2 Milton Keynes General NHS Trust 100 25 25 South Buckinghamshire NHS Trust 94 87 82 stoke Mandeville Hospital NHS Trust 100 51 51 Quarter 3 Milton Keynes General NHS Trust 100 49 49 South Buckinghamshire NHS Trust 95 100 95 Stoke Mandeville Hospital NHS Trust 100 68 68 Quarter4 Milton Keynes General NHS Trust 100 41 41 South Buckinghamshire NHS Trust 93 97 90 Stoke Mandeville Hospital NHS Trust 98 117 115 2000–01 Quarter 1 Milton Keynes General NHS Trust 97 59 57 South Buckinghamshire NHS Trust 94 108 101 Stoke Mandeville Hospital NHS Trust 100 90 90 Quarter 2 Milton Keynes General NHS Trust 92 59 54 South Buckinghamshire NHS Trust 94 83 78 Stoke Mandeville Hospital NHS Trust 99 93 92 Quarter3 Milton Keynes General NHS Trust 90 79 71 South Buckinghamshire NHS Trust 98 85 83 Stoke Mandeville Hospital NHS Trust 99 121 120 Quarter4 Milton Keynes General NHS Trust 92 53 49 South Buckinghamshire NHS Trust 99 113 112 Stoke Mandeville Hospital NHS Trust 100 101 101 2001–02 Quarter 1 Milton Keynes General NHS Trust 100 78 78 South Buckinghamshire NHS Trust 89 102 91 Stoke Mandeville Hospital NHS Trust 96 121 116 Quarter2 Milton Keynes General NHS Trust 100 51 51 South Buckinghamshire NHS Trust 65 112 73 Stoke Mandeville Hospital NHS Trust 98 91 89 Quarter3 Milton keynes General NHS Trust 100 96 96 South Buckinghamshire NHS Trust 99 106 105 Stoke Mandeville Hospital NHS Trust 94 124 116 Quarter4 Milton keynes General NHS Trust 100 78 78 South Buckinghamshire NHS Trust 100 94 94 Stoke Mandeville Hospital NHS Trust 100 96 96 2002–03 Quarter 1 Milton Keynes General NHS Trust 94 93 87 South Buckinghamshire NHS Trust 95 103 98 Stoke Mandevile Hospital NHS Trust 100 114 114
Waiting times for patients referred urgently by their Gp with suspected breast cancer to first out-patient appointment: NHS Trusts in Buckinghamshire Quarter/NHS Trust percentage of patients seen in two weeks Total patients seen patients seen in two weeks Quarter 2 Milton Keynes General NHS Trust 96 80 77 South Buckinghamshire NHS Trust 100 106 106 Stoke Mandeville Hospital NHS Trust 100 116 116 Quarter 3 Milton Keynes General NHS Trust 97 93 90 South Buckinghamshire NHS Trust 100 124 124 Stoke Mandeville Hospital NHS Trust 100 126 126 Quarter 4 Milton Keynes General NHS Trust 100 72 72 South Buckinghamshire NHS Trust 98 124 122 stoke Mandeville Hospital NHS Trust 100 124 124 2003–04 Quarter 1 Buckinghamshire Hospitals NHS Trust 100 236 235 Milton Keynes General NHS Trust 100 67 67 Quarter 2 Buckinghamshire Hospitals NHS Trust 99 263 261 Milton Keynes General NHS Trust 100 80 80
Number of prescription items of Oestrogens and HRT drugs that were dispensed in the community in England, 1997–2002 thousands Number of Prescription items Chemical Entity 1997 1998 1999 2000 2001 2002 Estradiol 1,139.6 1,164.7 1,176.4 1,186.4 1,202.6 1,167.1 Estradiol and Estriol — — — 0.0 0.0 — Estradiol and Estriol with progestogen 166.7 142.0 118.8 101.6 86.3 69.8 Estradiol Valerate 244.2 258.5 271.7 282.7 291.4 283.2 Estradiol with Cyproterone Acetate — — 0.0 0.0 0.0 0.0 Estradiol with Progestogen 1,228.8 1,337.4 1,426.5 1,552.3 1,638.5 1,597.3 Estradiol, Estriol and Estrone 76.1 76.4 69.9 68.4 68.2 63.6 Estriol 1.9 1.8 1.9 2.0 2.2 2.1 Estropipate 63.7 58.9 56.4 52.0 46.6 39.6 Estropipate with Progestogen 3.4 3.0 0.9 0.0 0.0 — Esthinylestradiol 36.2 32.3 30.2 28.1 26.5 23.9 Mestranol With Progestogen 16.2 13.7 7.3 0.1 — 0.0 Oestrogens Conjugated 1,120.5 1,101.0 1,091.5 1,080.9 1,058.5 976.3 oestrogens Conjugated with Progestogen 1,409.2 1,392.6 1,355.8 1,317.5 1,269.8 1,113.3 Oestrogens Esterified With Androgen — — 0.0 0.0 0.0 0.0 other Preparations 0.0 0.0 0.0 0.0 — — Raloxifene Hydrochloride — 4.1 43.4 79.9 119.0 160.7 Tibolone 334.3 349.0 387.5 425.4 454.3 464.2 Total for Oestrogens and HRT 5,840.8 5,935.6 6,038.2 6,177.5 6,263.8 5,961.0 Notes:
1. Oestrogens and HRT are defined as those drugs within the British National Formulary (BNF) paragraph 6.4.1.1.
2. The data are from the Prescription Cost Analysis system and cover all prescription items dispensed in the community in England.
Information on items dispensed in hospitals or private prescriptions is not available.
3."—" indicates non data. 0.0 indicates less than 50 items were dispensed.
source:
Prescription Cost Analysis (PCA) data from the Prescription Pricing Authority (PPA)